Biopharmaceutical, Workforce

The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) is pleased to announce approximately $15.8M in planned project activities through the Institute’s Project Call 5.2 for 14 new projects in technology and workforce development that will help to address key opportunities for innovation in the biopharmaceutical industry...

Manufacturing USA’s program office along with 7 manufacturing innovation institutes attended the Smart Manufacturing eXperience (SMX) in “Steel City,” Pittsburg, PA. With a focus on combating the challenges and opportunities to adopt smart manufacturing technologies faced by small and medium-sized manufacturers (SMMs) and others in the industry...

One year ago, President Biden signed Executive Order 14017 directing an all-of-government approach to assessing vulnerabilities in – and strengthening the resilience of – the United States’ critical supply chains. Within six months of taking office, the Administration completed a comprehensive review of the supply chains for four critical products...

Biomanufacturing, Biopharmaceutical, Collaboration, COVID-19, Innovation, Workforce

Today, the National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) announced 32 coronavirus response projects to multiple organizations across the United States funded through the American Rescue Plan (ARP).

NIIMBL identified projects that will help the nation prevent, prepare for, and respond to coronavirus public health...

Collaboration, COVID-19, Emerging Technologies, Manufacturing, Supply Chain, Sustainability, Workforce

This past year brought the country and our world unprecedented challenges, which now present opportunities to innovate and build a new path forward. Using lessons from this year, the manufacturing industry is poised to undergo a transformation.

Supporting this work are the institutes that are part of Manufacturing USA®, a national network of public...